Results for incontinence translation from Dutch to German

mictiefrequentie, urine- incontinentie incontinence
häufige miktion, harninkontinenz

frequent urineren, urine-incontinentie incontinence
häufige miktion, harninkontinenz

dogs hormone- dependent urinary incontinence (qg03ca04)
bovine

treatment of ileal pouch anal anastomosis (ipaa) related faecal incontinence
treatment of ileal pouch anal anastomosis (ipaa) related faecal incontinence

note for guidance on the clinical investigation of medicinal products for the treatment of urinary incontinence
note for guidance on the clinical investigation of medicinal products for the treatment of urinary incontinence

note for guidance on the clinical investigation of medicinal products for the treatment of urinary incontinence in women
note for guidance on the clinical investigation of medicinal products for the treatment of urinary incontinence in women

concept paper on the development of a cpmp note for guidance on the clinical investigation of medicinal products for the treatment of urinary incontinence in women
concept paper on the development of a cpmp note for guidance on the clinical investigation of medicinal products for the treatment of urinary incontinence in women

tijdens de dubbelblinde behandeling werd er bij kentera een significant positief effect op de kwaliteit van leven vastgesteld op basis van de incontinence impact questionnaire (iiq).
nach den ergebnissen des fragebogens zu den auswirkungen von inkontinenz (iiq: incontinence impact questionnaire) ergab sich während der doppelt verblindeten behandlung mit kentera ein signifikant positiver effekt auf die lebensqualität.

adjustment for multiplicity and related topics points to consider on biostatistical/methodological issues arising from cpmp discussion on licensing applications: adjustment for baseline covariates points to consider on clinical investigation of medicinal products in the treatment of asthma note for guidance on the clinical investigation of medicinal products for the treatment of urinary incontinence in women note for guidance on the evaluation of medicinal products for treatment of migraine appendix to the cpmp note for guidance on the clinical investigation of medicinal products in the treatment of schizophrenia, on methodology of clinical trials concerning the development of depot preparations of approved medicinal products in schizophrenia note for guidance on the evaluation of medicinal products indicated for thrombolysis in acute myocardial infarction addendum on acute cardiac failure to the cpmp note for guidance on clinical investigation of medicinal products in the treatment of acute cardiac failure note for guidance on the evaluation of medicinal products for treatment of dyslipoproteinaemia points to consider on clinical investigation of slow-acting anti-rheumatic medicinal products in rheumatoid arthritis points to consider on irritable bowel syndrome points to consider document on the evaluation of new anti-fungal agents for invasive fungal infections points to consider on biostatistical/methodological issues arising from cpmp discussion on licensing applications:
adjustment for baseline covariates points to consider on the clinical investigation of medicinal products in the treatment of asthma note for guidance on the clinical investigation of medicinal products for the treatment of urinary incontinence in women note for guidance on the evaluation of medicinal products for treatment of migraine appendix to the cpmp note for guidance on the clinical investigation of medicinal products in the treatment of schizophrenia, on methodology of clinical trials concerning the development of depot preparations of approved medicinal products in schizophrenia note for guidance on the evaluation of medicinal products indicated for thrombolysis in acute myocardial infarction addendum on acute cardiac failure to the cpmp note for guidance on clinical investigation of medicinal products in the treatment of acute cardiac failure note for guidance on the evaluation of medicinal products for the treatment of dyslipoproteinaemia points to consider on clinical investigation of slow-acting anti-rheumatic medicinal products in rheumatoid arthritis points to consider on irritable bowel syndrome points to consider document on the evaluation of new anti-fungal agents for invasive fungal infections points to consider on biostatistical/methodological issues arising from cpmp discussion on licensing applications: